Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies

Study Questions:

What is the risk of heart valve disease, including Libman-Sacks endocarditis, associated with antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?